Trial Outcomes & Findings for DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance (NCT NCT02403180)

NCT ID: NCT02403180

Last Updated: 2016-08-18

Results Overview

Stereoacuity (SA) is the ability to detect differences in distance (depth perception). Near SA was measured at a distance of 40 cm using the Howard-Dolman system. A lower SA value indicates better depth perception.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

70 participants

Primary outcome timeframe

Day 5, each product

Results posted on

2016-08-18

Participant Flow

Participants were recruited from one investigational center located in Spain.

This reporting group includes all enrolled participants (70).

Participant milestones

Participant milestones
Measure
DACP MF, Then PROCLEAR 1D MF
Nelfilcon A contact lenses were worn in Period 1, followed by omafilcon A contact lenses in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
PROCLEAR 1D MF, Then DACP MF
Omafilcon A contact lenses were worn in Period 1, followed by nelfilcon A contact lenses in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
Pre-Treatment Period
STARTED
36
34
Pre-Treatment Period
COMPLETED
36
33
Pre-Treatment Period
NOT COMPLETED
0
1
Period 1 (5 Days)
STARTED
36
33
Period 1 (5 Days)
Randomized
36
33
Period 1 (5 Days)
COMPLETED
36
33
Period 1 (5 Days)
NOT COMPLETED
0
0
Period 2 (5 Days)
STARTED
36
33
Period 2 (5 Days)
COMPLETED
36
32
Period 2 (5 Days)
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
DACP MF, Then PROCLEAR 1D MF
Nelfilcon A contact lenses were worn in Period 1, followed by omafilcon A contact lenses in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
PROCLEAR 1D MF, Then DACP MF
Omafilcon A contact lenses were worn in Period 1, followed by nelfilcon A contact lenses in Period 2. Both products were worn bilaterally (in both eyes) for 5 ±1 days in a daily wear, daily disposable modality.
Pre-Treatment Period
Withdrawal by subject prior to treatment
0
1
Period 2 (5 Days)
Withdrawal by Subject
0
1

Baseline Characteristics

DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
DACP MF, Then PROCLEAR 1D MF
n=36 Participants
Nelfilcon A contact lenses were worn in Period 1, followed by omafilcon A contact lenses in Period 2.
PROCLEAR 1D MF, Then DACP MF
n=34 Participants
Omafilcon A contact lenses were worn in Period 1, followed by nelfilcon A contact lenses in Period 2.
Total
n=70 Participants
Total of all reporting groups
Age, Continuous
51.7 years
STANDARD_DEVIATION 4.67 • n=5 Participants
50.4 years
STANDARD_DEVIATION 3.88 • n=7 Participants
51.1 years
STANDARD_DEVIATION 4.32 • n=5 Participants
Age, Customized
41-50 years
15 participants
n=5 Participants
20 participants
n=7 Participants
35 participants
n=5 Participants
Age, Customized
51-60 years
20 participants
n=5 Participants
13 participants
n=7 Participants
33 participants
n=5 Participants
Age, Customized
61-65 years
1 participants
n=5 Participants
1 participants
n=7 Participants
2 participants
n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
26 Participants
n=7 Participants
48 Participants
n=5 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
8 Participants
n=7 Participants
22 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 5, each product

Population: Intention to treat participants with non-missing observations

Stereoacuity (SA) is the ability to detect differences in distance (depth perception). Near SA was measured at a distance of 40 cm using the Howard-Dolman system. A lower SA value indicates better depth perception.

Outcome measures

Outcome measures
Measure
Proclear 1 Day MF
n=69 Participants
Omafilcon A contact lenses were worn for 5 days in Period 1 or Period 2.
DACP MF
n=68 Participants
Nelfilcon A contact lenses were worn for 5 days in Period 1 or Period 2.
Mean Stereoacuity at Near After 5+/-1 Days of Contact Lens Wear
40.6 arcsec
Standard Deviation 11.67
30.7 arcsec
Standard Deviation 8.67

SECONDARY outcome

Timeframe: Day 5, each product

Population: Intention to treat participants with non-missing observations

Visual acuity was measured with contact lenses in place using an Early Treatment Diabetic Retinopathy Study (ETDRS) high contrast logMAR chart under well-lit conditions. Trial Lenses of different spherical powers (+2.00 diopter to -5.00 diopter) were placed in front of the eyes to produce varying levels of defocus, and logMAR acuity at each defocus value was recorded. The area under the defocus curve (AUC) was calculated via the trapezoidal rule for the entire study population by treatment using a 0.3 logMAR threshold for intermediate from -2.00 D (50cm) to -0.50 D (2m) and near from -4.00 D (25cm) to -2.00 D (50cm). A higher value indicates a bigger area of focus.

Outcome measures

Outcome measures
Measure
Proclear 1 Day MF
n=69 Participants
Omafilcon A contact lenses were worn for 5 days in Period 1 or Period 2.
DACP MF
n=68 Participants
Nelfilcon A contact lenses were worn for 5 days in Period 1 or Period 2.
Mean Area of Focus Under the Mean Defocus Curve After 5 +/- 1 Days of Contact Lens Wear
for the Near Region
0.04 diopter*logMar
Standard Deviation 0.051
0.07 diopter*logMar
Standard Deviation 0.061
Mean Area of Focus Under the Mean Defocus Curve After 5 +/- 1 Days of Contact Lens Wear
for the Intermediate Region
0.17 diopter*logMar
Standard Deviation 0.092
0.21 diopter*logMar
Standard Deviation 0.077

Adverse Events

Proclear 1 Day MF

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

DACP MF

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Global Medical Affairs Franchise Head, Vision Care

Alcon Research, Ltd.

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER